Differential expression of protein kinase C isoforms in diethylnitrosamine-initiated rat liver

Cancer Letters

Volumn 126, Issue 1, 1998, Pages 17-22

  Lee, Yun Sil ^a   Hong, Seok Il ^a   Lee, Min Jae ^b   Kim, Mee Rhan ^b   Jang, Ja June ^b  

^a Korea Cancer Center Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Diethylnitrosamine; Initiation; Liver; Protein kinase C isoforms; Rat

Indexed keywords

DIETHYLNITROSAMINE; ISOENZYME; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENZYME LOCALIZATION; LIVER CARCINOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CARCINOGENS; DIETHYLNITROSAMINE; FEMALE; ISOENZYMES; LIVER NEOPLASMS; PROTEIN KINASE C; PROTEIN KINASE C-EPSILON; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

ANIMALIA;

EID: 0344447108     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00514-4     Document Type: Article

References (33)

1. Schere E., Emmelot P. Kinetics of induction and growth of precancerous liver-cell foci and liver tumor formation by diethylnitrosamine in the rat. Eur. J. Cancer. 11:1975;689-696.
2. Goldworthy T.L., Pitot H.C. An approach to the development of a short-term whole animal bioassay to distinguish initiating agents, promoting agents, complete carcinogens, and noncarcinogens in rat liver. J. Toxicol. Environ. Health. 16:1985;389-402.
3. Pitot H., Campbell H., Maronpot R., Bawa N., Rizvi T., Xu Y.H., Sargent L., Dragan Y., Pyron M. Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat. Toxicol. Pathol. 17:1989;594-612.
4. Goodnight J., Mischak H., Mushinski J.F. Selective involvement of protein kinase C isozyme in differentiation and neoplastic transformation. Adv. Cancer Res. 64:1994;159-209.
5. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature. 334:1988;661-665.
6. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:1992;607.
7. Stabel S., Parker P.J. Protein kinase C. Pharmacol. Ther. 51:1991;71-95.
8. Azzi A., Boscobonik D., Hensey C. Protein kinase C family. Eur. J. Biochem. 208:1992;547-557.
9. Wetsel W.C., Khan W.A., Merchenthaler I., Rivera H., Halpern A.E., Phung H.M., Negro-Vilar A., Hannun Y.A. Tissue and cellular distribution of the extended family of protein kinase C isozymes. J. Cell Biol. 117:1992;121-133.
10. Rogue P., Labourdette G., Masmoudi A., Yoshida Y., Huang F.L., Huang K.P., Zwiller J., Vincendon G., Malviya A.N. Rat liver nuclei protein kinase C is the isozyme type II. J. Biol Chem. 265:1990;4161-4165.
11. Raptis L., Marcellus R.C., Whitfield J.F. High membrane-associated protein kinase C activity correlates to tumorigenicity but not anchorage-independence in a clone of mouse NIH3T3 cells. Exp. Cell Res. 207:1993;152-154.
12. Hsiao W.-L.W., Housey G.M., Johnson M.D., Weinstein I.B. Cells that overproduce protein kinase C are hypersensitive to transformation by an activated H-ras oncogene. Mol. Cell. Biol. 9:1989;2641-2647.
13. Berra E., Diaz-Meco M.T., Dominguez I., Municio M.M., Sanz L., Lozano J., Chapkin R.S., Moscat J. Protein kinase C zeta isoform is critical for mitogenic signal transduction. Cell. 74:1993;555-563.
14. Cacace A.M., Guadagno S.N., Krauss R.S., Fabbro D., Weinstein I.B. The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene. 8:1993;2095-2104.
15. Hanania N., Lezenes J.R., Castagna M. Tumorigenicity associated expression of protein kinase C isoforms in rhabdomyosarcoma derived cells. FEBS Lett. 303:1992;15-18.
16. O'Brien C.A., Vogel V.G., Singletary S.E., Ward N.E. Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res. 49:1989;3215-3217.
17. Mills K.J., Bocckino S.B., Burns D.J., Loomis C.R., Smart R.C. Alterations in protein kinase C isoenzymes a and b2 in activated Ha-ras containing papillomas in the absence of an increase of diacyl glycerol. Carcinogenesis. 13:1992;1113-1120.
18. Becker D., Beebe S.J., Herlin M. Differential expression of protein kinase C and c-AMP dependent protein kinase in normal human melanocytes and malignant melanomas. Oncogene. 5:1990;1133.
19. Hagiwara M., Hachiya T., Watanabe M., Usuda N., Iida K., Tamai K., Hidaka H. Assessment of protein kinase C isozymes by enzyme immunoassay and over-expression of type II in thyroid adenocarcinoma. Cancer Res. 50:1990;5515-5519.
20. Benzil D.L., Finkelstein S.D., Epstein M.H., Finch P.W. Expression pattern of alfa protein kinase C in human astrocytomas indicates a role in malignant progression. Cancer Res. 52:1992;2951-2956.
21. La Porta C.A.M., Perletti G.P., Piccinini F., Comolli R. Analysis of calcium-dependent protein kinase C isoforms in the early stages of diethylnitrosamine-induced rat hepatocarcinogenesis. Mol. Carcinog. 8:1993;255-263.
22. Blumberg P.M. Complexities of the protein kinase C pathway. Mol. Carcinog. 4:1991;339-344.
23. Kikkawa U., Nishizuka Y. The role of protein kinase C in transmembrane signaling. Annu. Rev. Cell Biol. 2:1986;149-178.
24. J.E. Niedel, P.J. Blackshear, Protein kinase C, in: J.W. Putney (Ed.), Phosphoinositides and Receptor Mechanisms, Alan R. Liss, New York, 1986, pp. 47-88.
25. Burkley A.T., Putman C.W., Evans R., Laird H.E., Shah G.N., Montgomery D.W., Russel D.H. Hepatic protein kinase C: translocation stimulated by prolactin and partial hepatectomy. Life Sci. 41:1987;2827-2834.
26. Okamoto Y., Nishimura K., Nakayama M., Nakagawa M., Nakano H. Protein kinase C in the regenerating rat liver. Biochem. Biophys. Res. Commun. 151:1988;1144-1149.
27. Colapietro A.M., Goodell A.L., Smart R.C. Characterization of benzo(a)pyrene-initiated mouse skin papillomas for Ha-ras mutations and protein kinase C levels. Carcinogenesis. 14:1993;2289-2295.
28. Tessitore L., Perletti G.P., Sesca E., Pani P., Dianzami M.U., Piccinini F. Protein kinase C isozyme pattern in liver hyperplasia. Biochem. Biophys. Res. Commun. 205:1994;208-214.
29. Orr J.W., Newton A.C. Intrapeptide regulation of protein kinase C. J. Biol. Chem. 269:1994;8383-8387.
30. Wetsel W.C., Khan W.A., Merchenthaler I., Rivera H., Halpern A.E., Phung H.M., Negro-Vilar A., Hannun Y.A. Tissue and cellular distribution of the extended family of protein kinase C isoenzyme. J. Cell Biol. 117:1992;121-133.
31. Ono Y., Fujii T., Ogita K., Kikkawa U., Igarashi K., Nishizuka Y. The structure, expression, and properties of additional members of the protein kinase C family. J. Biol. Chem. 263:1988;6927-6932.
32. Mischak H., Goodnight J., Kolch W., Martiny-Baron G., Schaechtle C., Kazanietz M.G., Blumberg P.M., Pierce J.H., Mushinski J.F. Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J. Biol. Chem. 268:1993;6090-6096.
33. La Porta C.A.M., Comolli R. Membrane and nuclear protein kinase C activation in the early stages of diethylnitrosamine-induced rat hepatocarcinogenesis. Carcinogenesis. 15:1994;1743-1747.